Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Iva Staniczková Zambo"'
Autor:
Danica Zapletalová, Jan Skoda, Markéta Hermanová, Karel Zitterbart, Renata Veselská, Michal Kyr, Iva Staniczková Zambo, Jaroslav Sterba, Peter Múdry
Publikováno v:
Cancer biomarkers : section A of Disease markers. 17(1)
Nestin, CD133 and ABCG2 are recently discussed as putative markers, co-expression of which might determine a cancer stem cell (CSC) phenotype in sarcomas. Our study is focused on immunohistochemical analysis of nestin, CD133 and ABCG2 expression in r
Autor:
Iva Staniczková Zambo, Renata Veselská, Markéta Hermanová, Jakub Neradil, Peter Múdry, Jaroslav Sterba, Tomáš Loja, Aleš Hampl, Karel Zitterbart, Alena Nunukova, Jan Skoda
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(7)
The three most frequent pediatric sarcomas, i.e., Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma, were examined in this study: three cell lines derived from three primary tumor samples were analyzed from each of these tumor types. Detailed compa
Autor:
Renata Veselská, Markéta Hermanová, Jaroslav Sterba, Tomáš Loja, Karel Zitterbart, Karel Vesely, Iva Staniczková Zambo, Petr Chlapek
Publikováno v:
BMC Cancer
BMC Cancer, Vol 8, Iss 1, p 300 (2008)
BMC Cancer, Vol 8, Iss 1, p 300 (2008)
Background Nestin was originally identified as a class VI intermediate filament protein that is expressed in stem cells and progenitor cells in the mammalian CNS during development. This protein is replaced in the adult organism by other intermediate